REG - Induction Healthcare - AGM Statement

Induction HealthcareAnnouncement

04/11/2021 07:00

RNS Number : 2799R
  
Induction Healthcare Group PLC 
  
04 November 2021
  
 

Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
 
AGM Statement
£11.2m contracted revenues already secured for the current financial year
 
Induction (AIM: INHC), a leading virtual care platform driving digital transformation of healthcare systems worldwide, provides an update to shareholders ahead of its Annual General Meeting ('AGM') being held today at 50 Liverpool Street, London EC2M 7PY at 9.00 am.
 
At the meeting James Balmain, Chief Executive Officer, will make the following statement:
 
"I am very pleased to welcome shareholders to our Annual General Meeting and to provide them with a short update on the strong performance we have experienced in the first half of the new financial year, underpinning our expectations for the full year. 
 
"As highlighted in our recent Final Results statement we continue to see growing demand for our flexible care platforms. As health systems around the world continue to execute their pandemic recovery plans, we're seeing rapidly increasing levels of investment from both local providers and regional care systems. The acquisition of Attend Anywhere in June further enhances our leading market position and gives us comprehensive coverage of the secondary care patient pathway by allowing us to offer appointment booking, remote data capture and the full range of telephone and video consultations.
 
"The Group currently has £11.2m of contracted revenues secured for the financial year ending 31 March 2022, and the integration and realisation of cost synergies with Attend Anywhere are proceeding better than expected and this is providing the Board with confidence that we are in line to meet market expectations for the full year.
 
"We go into the remainder of the financial year with a strong pipeline of potential new contracts and renewals, and we continue to see a substantial increase in patient and clinical users. We are very excited about the prospects for the Company and look forward to updating shareholders as our strong sales momentum continues."
 
 
ENQUIRIES
 



Induction
James Balmain, Chief Executive Officer
Dr Hugo Stephenson, Group Executive Director


Via Walbrook PR Ltd: induction@walbrookpr.com














Singer Capital Markets (Nominated Adviser and Broker)


+44 (0) 20 7496 3000




Philip Davies / Kailey Aliyar 


















Walbrook PR Ltd 


induction@walbrookpr.com




Paul McManus / Alice Woodings


Mob: +44(0)7980 541 893 / +44 (0)7407 804 654 



 
About Induction - www.inductionhealthcare.com
 
Induction (AIM: INHC) is a leading virtual care platform driving digital transformation of healthcare systems worldwide. Induction solutions enhance the investments hospitals have made and lay the foundation for their future. Our products can enable information sharing between busy doctors, alleviate operational burdens on hospitals or put patients in better control of their care, all while ensuring the highest standards of clinical safety and information security. We unchain staff and patients from the limitations of paper-based and desktop systems, creating substantial time and cost efficiencies.
 
More than 225,000 hospital doctors across multiple territories, including the UK, Ireland, Australia and South Africa, as well as a rapidly growing number of more than 300,000 UK patients, choose Induction solutions.
 
Induction Switch is the number one healthcare collaboration app in the UK, used by the majority of hospital doctors within the NHS. The app helps to increase productivity and enhance communication by securely sharing phone numbers and bleeps, bookmarks, documents and messages in a clinical setting.
 
Induction Guidance provides medical organisations, including most hospital trusts within the NHS, with the ability to collaboratively create, edit, and publish their own local medical guidelines in a secure and locally administrated environment. This increases knowledge of, and adherence to, guidance.
 
Induction Zesty is a market-leading digital platform for patients visiting hospitals. The platform allows patients to book and access their appointments, read their clinical letters, store a copy of their clinical record and provide data to their care teams remotely. It is not just a compelling patient experience, but also delivers significant cost benefits to hospitals.
 
Induction Attend Anywhere is the UK market leader in secondary care video consultations. It helps hospitals, health systems and other customers offer video consultations to patients and service users as a normal part of day-to-day clinical activity. Our vision is for video consultations to improve lives and help address social, access, equity and sustainability challenges by allowing healthcare providers to determine how and when they see a patient based on each individual case: in-person, via video or on the telephone. 
 
Induction HealthStream is a proprietary data integration platform that reads and writes patient demographic, appointment and clinical record data between a growing number of hospital EHR systems and the Induction platforms. This connectivity between stakeholders and legacy IT systems adds substantial value to pre-existing health IT investment and allows large-scale adoption of Induction app-based services.
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
AGMFSFFUDEFSESF